Valsartan (Diovan)
ATI-format individual drug card with NCLEX-focused assessment, safety, teaching, and source attribution.
Valsartan (Diovan)
ATI class: ARB / Angiotensin II receptor blocker
Action
- ATI/source-folder candidate for Valsartan (Diovan); verify mechanism against the source table before validation.
Therapeutic use
- Review under Hypertension / Heart Failure medication safety.
Nursing assessment
- Monitor blood pressure, potassium, creatinine, BUN, and urine output.
- Assess pregnancy status, dizziness, kidney perfusion risk, and angioedema symptoms.
- Review potassium supplements, salt substitutes, NSAIDs, and potassium-sparing diuretics.
Administration
- Verify route against the order and source table.
Side effects
- Verify common side effects against the source table.
Adverse effects
- Hyperkalemia
- Hypotension
- Kidney function decline
- Angioedema
- Dizziness
Interactions
- Potassium supplements
- Salt substitutes
- Potassium-sparing diuretics
- NSAIDs
- Lithium
- Aliskiren in selected clients
Contraindications
- See source-specific contraindications and precautions before administration.
Precautions
- Pregnancy.
- Use caution with renal artery stenosis, kidney disease, high potassium, and volume depletion.
- Question severe hypotension or rising creatinine after initiation.
Client teaching
- Avoid pregnancy and notify the provider immediately if pregnancy occurs.
- Avoid potassium salt substitutes unless approved.
- Report facial swelling, fainting, muscle weakness, palpitations, or low urine output.
Medication outcomes
- Therapeutic response with no priority adverse effects.
Antidote / rescue
- No specific antidote is seeded; hold/question unsafe doses and manage toxicity per provider, facility, or poison-control guidance.
NCLEX priority cues
- Pregnancy with an ARB is a high-priority medication safety cue.
- Hyperkalemia symptoms require prompt review.
- Angioedema remains possible even without ACE-inhibitor cough.
Medication classes
Source attribution
Related study cards
Shows the medication class, ATI cues, source references, and connected study cards for this drug.
Reduces angiotensin effect so vessels relax and aldosterone-driven sodium and water retention decreases.
ATI medication interaction concept.
ATI medication adverse effect concept.
ATI medication nclex priority cue concept.
ATI medication class concept.
ATI medication class concept.
ATI medication nursing assessment concept.
ATI medication mechanism of action concept.
ATI medication client teaching concept.
ATI medication client teaching concept.
ATI medication adverse effect concept.
ATI medication adverse effect concept.